Drug Shortage Report for JANUMET XR

Last updated on 2021-12-14 History
Report ID 150734
Drug Identification Number 02416794
Brand name JANUMET XR
Common or Proper name sitagliptin and metformin hydrochloride modified-release tablets
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE SITAGLIPTIN
Strength(s) 1000MG 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-12-07
Estimated end date 2021-12-13
Actual end date 2021-12-13
Shortage status Resolved
Updated date 2021-12-14
Company comments Shortage due to quality testing delay
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-12-14 English Compare
v4 2021-12-13 French Compare
v3 2021-12-13 English Compare
v2 2021-12-08 French Compare
v1 2021-12-08 English Compare

Showing 1 to 5 of 5